Articoli GVHD Graft-versus-Host Disease IBS IBD BUTIRRATO COVID-19 LINEE GUIDA RADIOTERAPIA BARRIERA EPITELIALE INTESTINALE RIGENERAZIONE CUTANEA IDROSADENITE SUPPURATIVA MALATTIE METABOLICHE GVHD - Graft-versus-Host Disease MALATTIA DIVERTICOLARE Microbiota-derived short-chain fatty acids in hematopoietic stem cell transplantation: immunomodulation at the host-microbiota interfaceacidi grassi a catena corta (SCFA)asse intestino-immunitàbarriera intestinalebutirratomalattia del trapianto contro l'ospite (GvHD)microbiota intestinaleregolazione epigeneticatrapianto di cellule staminali ematopoietiche (HSCT)Oral Sodium Butyrate Supplementation, Gut Microbiome Modulation, and Reduced Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell TransplantationaGVHDallo HSCTbutirratoThe microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHDGHVDpropionatoSCFAs butirratoGut microbiota diversity before allogeneic hematopoietic stem cell transplantation as a predictor of mortality in childrenallo HSCTGVHDSCFAsThe microbiome in graft-versus-host disease: a tale of two ecosystemsAcidi grassi a catena cortaGVHDmalattia del trapianto contro l'ospitemicrobiomarisposta immunitariatrapianto allogenico di cellule staminali ematopoieticheDiet-derived metabolites and mucus link the gut microbiome to fever after cytotoxic cancer treatmentAkkermansia MuciniphilaMuco SCFAsNeutropeniaResearch advances on short-chain fatty acids in gastrointestinal acute graft-versus-host diseaseallo HSCTGVHDSCFAsMicrobiome Modulation in Pediatric Leukemia: Impact on Graft-Versus-Host Disease and Treatment Outcomes: A Narrative ReviewALL-HSCTGVHDleucemia infantile; microbioma intestinaletrapianto di microbiota fecale FMTFecal microbiota transplantation for refractory chronic graft‑versus‑host disease after allogeneic hematopoietic cell transplantation: a pilot open‑label, Non‑placebo‑controlled studyBMC MeduOral Sodium Butyrate Supplementation, Gut Microbiome Modulation, and Reduced Acute GraftVersus-Host Disease After Allogeneic Hematopoietic Stem Cell TransplantationaGVHDallo HSCTbutirrato
Microbiota-derived short-chain fatty acids in hematopoietic stem cell transplantation: immunomodulation at the host-microbiota interfaceacidi grassi a catena corta (SCFA)asse intestino-immunitàbarriera intestinalebutirratomalattia del trapianto contro l'ospite (GvHD)microbiota intestinaleregolazione epigeneticatrapianto di cellule staminali ematopoietiche (HSCT)
Oral Sodium Butyrate Supplementation, Gut Microbiome Modulation, and Reduced Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell TransplantationaGVHDallo HSCTbutirrato
The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHDGHVDpropionatoSCFAs butirrato
Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as a predictor of mortality in childrenallo HSCTGVHDSCFAs
The microbiome in graft-versus-host disease: a tale of two ecosystemsAcidi grassi a catena cortaGVHDmalattia del trapianto contro l'ospitemicrobiomarisposta immunitariatrapianto allogenico di cellule staminali ematopoietiche
Diet-derived metabolites and mucus link the gut microbiome to fever after cytotoxic cancer treatmentAkkermansia MuciniphilaMuco SCFAsNeutropenia
Research advances on short-chain fatty acids in gastrointestinal acute graft-versus-host diseaseallo HSCTGVHDSCFAs
Microbiome Modulation in Pediatric Leukemia: Impact on Graft-Versus-Host Disease and Treatment Outcomes: A Narrative ReviewALL-HSCTGVHDleucemia infantile; microbioma intestinaletrapianto di microbiota fecale FMT
Fecal microbiota transplantation for refractory chronic graft‑versus‑host disease after allogeneic hematopoietic cell transplantation: a pilot open‑label, Non‑placebo‑controlled studyBMC Medu
Oral Sodium Butyrate Supplementation, Gut Microbiome Modulation, and Reduced Acute GraftVersus-Host Disease After Allogeneic Hematopoietic Stem Cell TransplantationaGVHDallo HSCTbutirrato